OBSOLETE: Cortada-Koussef-Matsumoto syndrome
ORPHA:1499OBSOLETE: Epidermal nevus-vitamin D-resistant rickets syndrome
ORPHA:2694OBSOLETE: Intellectual disability-cataracts-kyphosis syndrome
ORPHA:171860OBSOLETE: Multiple ventricular septal defects
ORPHA:99096OBSOLETE: Other immunodeficiency syndrome with predominantly antibody defects
ORPHA:331244OBSOLETE: Poliomyelitis in patients with immunodeficiencies deemed at risk
ORPHA:330009OBSOLETE: Postsurgical hypopituitarism
ORPHA:95621OBSOLETE: Rare variants of adenocarcinoma of the corpus uteri
ORPHA:213574OBSOLETE: Shoulder and girdle defects-familial intellectual disability syndrome
ORPHA:2580OBSOLETE: Terminal limb defects
ORPHA:294929OBSOLETE: Terminal transverse defects of arm
ORPHA:93937Oculoauriculovertebral spectrum with radial defects
ORPHA:2549Odonto-onycho-hypohidrotic dysplasia-midline scalp defects syndrome
ORPHA:3391Other immunodeficiency syndromes due to defects in innate immunity
ORPHA:331193Partial bilateral aplasia of the Müllerian ducts
ORPHA:180068Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome
ORPHA:401959Piebald trait-neurologic defects syndrome
ORPHA:2885Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome
ORPHA:447961Pituitary deficiency due to Rathke cleft cysts
ORPHA:91350Pituitary dermoid and epidermoid cysts
ORPHA:91351Postsynaptic congenital myasthenic syndrome
ORPHA:98913Primary bone dysplasia with disorganized development of skeletal components
ORPHA:93450Primary bone dysplasia with progressive ossification of skin, skeletal muscle, fascia, tendons and ligaments
ORPHA:364531Primary qualitative or quantitative defects of alpha-dystroglycan
ORPHA:371040PRKAR1B-related neurodegenerative dementia with intermediate filaments
ORPHA:412066Pulmonary fungal infections in patients deemed at risk
ORPHA:217080Qualitative or quantitative defects of alpha-actin
ORPHA:209059Qualitative or quantitative defects of alpha-dystroglycan
ORPHA:371024Qualitative or quantitative defects of alpha-sarcoglycan
ORPHA:207060Qualitative or quantitative defects of alphaB-cristallin
ORPHA:209044Qualitative or quantitative defects of beta-myosin heavy chain (MYH7)
ORPHA:209185Qualitative or quantitative defects of beta-sarcoglycan
ORPHA:207063Qualitative or quantitative defects of calpain
ORPHA:207104Qualitative or quantitative defects of caveolin-3
ORPHA:207078Qualitative or quantitative defects of collagen 6
ORPHA:207090Qualitative or quantitative defects of delta-sarcoglycan
ORPHA:207070Qualitative or quantitative defects of desmin
ORPHA:209041Qualitative or quantitative defects of dysferlin
ORPHA:207073Qualitative or quantitative defects of dystrophin
ORPHA:207085Qualitative or quantitative defects of emerin
ORPHA:209188Qualitative or quantitative defects of filamin C
ORPHA:209047Qualitative or quantitative defects of FKRP
ORPHA:207119Qualitative or quantitative defects of fukutin
ORPHA:207122Qualitative or quantitative defects of gamma-sarcoglycan
ORPHA:207067Qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase -
ORPHA:209203Qualitative or quantitative defects of integrin alpha-7
ORPHA:207098Qualitative or quantitative defects of myofibrillar proteins
ORPHA:209038Qualitative or quantitative defects of myotubularin
ORPHA:207110